Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Sanofi, Boehringer Ingelheim to swap animal, consumer health assets Sanofi and Boehringer Ingelheim have signed contracts to exchange their respective animal health and consumer healthcare businesses. Production & Manufacturing > Manufacturing > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
Production & Manufacturing > Fine & Speciality Chemicals > News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News

Process & Production

EC grants orphan drug status to Mereo's BPS-804 for osteogenesis imperfecta
By PBR Staff Writer
Mereo BioPharma Group announced that its drug BPS-804 has been granted orphan drug designation by the European Commission (EC) in the treatment of osteogenesis imperfecta (OI).
Production & Manufacturing > Process & Production > News
FDA grants Imbruvica breakthrough therapy designation for cGVHD
By PBR Staff Writer
The US Food and Drug Administration (FDA) has granted a fourth Breakthrough Therapy designation (BTD) and an orphan drug designation for ibrutinib (Imbruvica) for the potential treatment of chronic graft-versus-host-disease (cGVHD) after failure of one or more lines of systemic therapy.
Production & Manufacturing > Process & Production > News

OTC

Moberg Pharma agrees to acquire three US OTC brands from Prestige Brands
Moberg Pharma has signed an agreement to acquire New Skin, Fiber Choice and PediaCare, three well-established Over-The-Counter brands in the U.S. from Prestige Brands.
Production & Manufacturing > OTC > News
VANC Pharmaceuticals signs definitive deal for filing two ANDS with exclusive marketing rights to Canada
VANC Pharmaceuticals, a pharmaceutical company focused on the Canadian generic drug and over-the-counter market, has entered into a definitive agreement for filing two abbreviated new drug submissions (ANDS) with exclusive marketing rights to Canada from an unnamed, manufacturer.
Production & Manufacturing > OTC > News

Manufacturing

Merck to develop vaccine manufacturing processes with International Vaccine Institute
Merck has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.
Production & Manufacturing > Manufacturing > News
Intensity Therapeutics raises $10m to fund clinical supplies manufacturing and phase I/II trials of INT230-6
Intensity Therapeutics, a privately held biotechnology company developing proprietary cancer immunotherapy products, has secured $10 million in new capital from a Series A preferred stock financing.
Production & Manufacturing > Manufacturing > News